Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M File

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremiaJohn Selickman, Mihail Paxos, Thomas M File, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for HospitalsDebra A Goff, Ravina Kullar, Karri A Bauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2017
Reply to Bush and KayeRavina Kullar, Debra A Goff, Karri A Bauer, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2007
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind studyThomas M File, Lionel A Mandell, Glenn Tillotson, et al.
Journal of Chemotherapy (Florence, Italy)|March 14, 2014
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patientsTimothy R Pasquale, Michael J Tan, Tamara L Trienski, et al.
Postgraduate Medicine|June 14, 2012
Identifying barriers to adult pneumococcal vaccination: an NFID task force meetingSusan J Rehm, Thomas M File, Mark Metersky, et al.
Clinical Therapeutics|December 28, 2002
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerabilityHartmut Lode, Thomas M File, Lionel Mandell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2012
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaMark L Metersky, Robert G Masterton, Hartmut Lode, et al.
Hospital Practice (1995)|January 10, 2017
Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort studyChristopher J Llop, Edward Tuttle, Glenn S Tillotson, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremiaJohn Selickman, Mihail Paxos, Thomas M File, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for HospitalsDebra A Goff, Ravina Kullar, Karri A Bauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2017
Reply to Bush and KayeRavina Kullar, Debra A Goff, Karri A Bauer, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2007
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind studyThomas M File, Lionel A Mandell, Glenn Tillotson, et al.
Journal of Chemotherapy (Florence, Italy)|March 14, 2014
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patientsTimothy R Pasquale, Michael J Tan, Tamara L Trienski, et al.
Postgraduate Medicine|June 14, 2012
Identifying barriers to adult pneumococcal vaccination: an NFID task force meetingSusan J Rehm, Thomas M File, Mark Metersky, et al.
Clinical Therapeutics|December 28, 2002
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerabilityHartmut Lode, Thomas M File, Lionel Mandell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2012
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaMark L Metersky, Robert G Masterton, Hartmut Lode, et al.
Hospital Practice (1995)|January 10, 2017
Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort studyChristopher J Llop, Edward Tuttle, Glenn S Tillotson, et al.
Pageof 16